Scotiabank Comments on Exelon’s FY2025 Earnings (NASDAQ:EXC)

Exelon Co. (NASDAQ:EXC) – Equities researchers at Scotiabank increased their FY2025 EPS estimates for Exelon in a report issued on Wednesday, March 19th. Scotiabank analyst A. Weisel now forecasts that the company will earn $2.71 per share for the year, up from their prior estimate of $2.62. Scotiabank has a “Sector Perform” rating and a $44.00 price objective on the stock. The consensus estimate for Exelon’s current full-year earnings is $2.64 per share. Scotiabank also issued estimates for Exelon’s FY2026 earnings at $2.85 EPS.

Exelon (NASDAQ:EXC) last issued its quarterly earnings results on Wednesday, February 12th. The company reported $0.64 earnings per share for the quarter, beating analysts’ consensus estimates of $0.59 by $0.05. Exelon had a return on equity of 9.52% and a net margin of 10.68%. During the same quarter in the prior year, the business earned $0.60 EPS.

EXC has been the topic of several other reports. BMO Capital Markets reaffirmed an “outperform” rating on shares of Exelon in a research report on Tuesday, February 4th. Morgan Stanley raised their price objective on Exelon from $46.00 to $48.00 and gave the company an “equal weight” rating in a research note on Thursday. Guggenheim upgraded Exelon from a “neutral” rating to a “buy” rating in a report on Thursday, January 23rd. Evercore ISI upgraded shares of Exelon from an “in-line” rating to an “outperform” rating and raised their target price for the company from $43.00 to $44.00 in a research note on Tuesday, January 21st. Finally, Barclays upped their price target on shares of Exelon from $42.00 to $48.00 and gave the company an “overweight” rating in a report on Tuesday, February 25th. Five analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, Exelon currently has a consensus rating of “Moderate Buy” and a consensus target price of $44.63.

Exelon Stock Up 0.3 %

EXC stock opened at $44.59 on Friday. The company has a quick ratio of 0.78, a current ratio of 0.87 and a debt-to-equity ratio of 1.61. Exelon has a 12-month low of $34.01 and a 12-month high of $45.20. The company has a 50 day moving average of $41.84 and a two-hundred day moving average of $39.91. The company has a market cap of $44.82 billion, a price-to-earnings ratio of 18.20, a PEG ratio of 2.86 and a beta of 0.51.

Exelon Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were issued a $0.40 dividend. The ex-dividend date was Monday, February 24th. This is a boost from Exelon’s previous quarterly dividend of $0.38. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.59%. Exelon’s dividend payout ratio is presently 65.31%.

Insider Buying and Selling at Exelon

In other news, EVP Colette D. Honorable sold 1,463 shares of Exelon stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $40.57, for a total value of $59,353.91. Following the completion of the transaction, the executive vice president now owns 2,271 shares in the company, valued at approximately $92,134.47. The trade was a 39.18 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.10% of the company’s stock.

Institutional Investors Weigh In On Exelon

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Norges Bank bought a new stake in shares of Exelon during the fourth quarter worth $479,597,000. Price T Rowe Associates Inc. MD lifted its position in Exelon by 37.2% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 27,618,055 shares of the company’s stock worth $1,039,545,000 after buying an additional 7,483,873 shares in the last quarter. FMR LLC grew its holdings in Exelon by 46.9% during the 4th quarter. FMR LLC now owns 17,306,652 shares of the company’s stock worth $651,422,000 after acquiring an additional 5,524,103 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in Exelon by 43.3% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 12,846,030 shares of the company’s stock valued at $483,525,000 after acquiring an additional 3,878,687 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its position in Exelon by 109.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 5,884,282 shares of the company’s stock valued at $238,608,000 after acquiring an additional 3,068,309 shares in the last quarter. 80.92% of the stock is owned by institutional investors and hedge funds.

About Exelon

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.